[Preparation of MCT-13 and investigation of its activity against hymenolepidosis].
Sevbo
D P
DP
Trusov
S N
SN
Malakhova
A Iu
AIu
Gitsu
G A
GA
Mikhaĭlitsyn
F S
FS
D000818:Animals; D000923:Anticestodal Agents / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D001549:Benzamides / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D004353:Drug Evaluation, Preclinical; D006925:Hymenolepiasis / Q000188:drug therapy*; D048189:Hymenolepis nana / Q000187:drug effects*; D051379:Mice
D000923:Anticestodal Agents; D001549:Benzamides; C551697:N-(4-methoxy-3-chlorophenyl)-2-hydroxy-3,5-dibromobenzamide